Latest Industry Insights

Industry Insight
Harnessing the Immune System To Combat Antimicrobial Resistance
Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first clinical candidate from the ABX-01 program and how the platform could help shape the future of anti-infective therapy.

Industry Insight
Anti-Infective Development Boosted by AI and Automation
Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.

Industry Insight
A Nutrient-Based Alternative to Weight Loss Drugs
Unlike injectable weight loss drugs that often serve as a temporary fix, Elcella seeks to naturally activate the gut’s own appetite-regulating mechanisms, offering a new path to long-term health and sustainable weight management.

Industry Insight
Making Single-Cell Functional Analysis Accessible to All
Today, single-cell technologies are not only dissecting genomic, transcriptomic and proteomic profiles but also enabling dynamic measurements of cellular functions. Bruker's new Beacon Discovery Platform could make this a reality for more labs.

Industry Insight
Funding Will Advance Third-Party Verified Sustainability in Science
James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.

Industry Insight
The Probiotic Designed To Work When Your Gut Is Under Attack
Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead product, FerrocalmTM, and how its innovative strategy could reshape the future of gut health.

Industry Insight
Tick-Borne Illness Diagnosis Enters New Era With Multiplex Testing
Technology Networks spoke to Jason Barker, ND, clinical lab educator at Vibrant Wellness, to explore why co-infections from tick bites are frequently underdiagnosed and to examine current and future testing protocols of tick-borne diseases.

Industry Insight
DNA Vaccines Offer a New Path Beyond mRNA Technology
In this interview, Technology Networks talked to Dr. Stacy Lindborg, president, chief executive officer and board member at IMUNON, Inc., who shares how its PlaCCine® platform could reshape vaccine development.

Industry Insight
T-Cell Priming Technology Strengthens Pandemic Preparedness
Technology Networks spoke to Professor Thomas Rademacher, co-founder, executive director and CEO at Gylden Pharma Limited, to learn more about T-cell priming vaccine technology and its potential to strengthen preparedness for future pandemics.

Industry Insight
Why Good Science Is Key to Good Technology
In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.
Advertisement